Flonase Ad Claims Settlement Confidential, But McNeil Likely Gains Choosing Court Over NAD
This article was originally published in The Tan Sheet
Executive Summary
When prompt action is a primary goal, as McNeil aimed for in challenging ad claims for Glaxo’s Flonase Allergy Relief, lawyers say going to court is a better option than going to the National Advertising Division. Even with allegations that wither under the opposing firm’s rebuttal, litigation of advertising complaints it gains publicity than a NAD review would generate.